Products mentioned by Daniel Witt
Products Daniel Witt has mentioned or recommended across podcast appearances.
SignalCast may earn a small commission on purchases through these links — at no extra cost to you. As an Amazon Associate we earn from qualifying purchases.
Tecfidera
“IMU-838 inhibits DHODH (the same target as approved MS drug Tecfidera) but also activates the NR1 nuclear receptor”
IMU-838
Authorby Immunic Therapeutics
“Immunic Therapeutics CEO Daniel Witt joins Beyond Biotech on World MS Day to discuss IMU-838, an oral therapy targeting the NR1 nuclear receptor with potential neuroprotective effects in both relapsing and progressive MS”
Ocrevus
“Drugs like Ocrevus deplete B-cells effectively but cannot be used indefinitely — declining IgG levels force physicians to discontinue treatment”